Form 4: Broadwood Partners Increases Stake in STAAR Surgical Co.

Broadwood Partners, L.P. reports increased ownership in STAAR Surgical Co. through recent stock purchases.

Summary

• Broadwood Partners, L.P. has reported changes in their beneficial ownership of STAAR Surgical Co. stock.
• On March 21, 2025, Broadwood Partners purchased 102,400 shares of common stock at a weighted average price of $17.7397, with prices ranging from $17.665 to $17.74.
• On March 25, 2025, they purchased an additional 34,296 shares at a weighted average price of $17.4416, with prices ranging from $17.26 to $17.49.
• Following these transactions, Broadwood Partners directly owns 12,319,691 shares.
• Neal C. Bradsher also directly owns 25,900 shares.
• Broadwood Capital, Inc., as General Partner of Broadwood Partners, and Neal C. Bradsher, as President of Broadwood Capital, may be deemed to indirectly beneficially own the reported securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating changes in ownership. The increased stake could be seen as slightly positive, but without further context, it's difficult to gauge the overall impact.

Positives

• Broadwood Partners increasing its stake in STAAR Surgical Co. could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing reflects activity in the market for STAAR Surgical Co. shares, a company in the ophthalmic surgical device industry. Monitoring ownership changes can provide insights into investor sentiment and potential future stock performance.

Stakeholder Impact

• Shareholders may react to the news of Broadwood Partners increasing its stake, potentially influencing the stock price.

Key Dates

Keywords

STAAR Surgical, Broadwood Partners, Beneficial Ownership, Stock Purchase, Form 4, STAA